01.11.23 -- Optimizing Clinical Supply And Resupply With Patient Centricity In Mind

Demand-led supply and direct-to-patient distribution are helping address challenges presented by today’s increasingly complex studies. Safeguarding the integrity of the study drugs through proper handling and keen quality oversight and ensuring continuity of supply are critical components.

Discover how to drive excellence within the forecasting process, how to utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines, and how to identify potential supply-related issues before they negatively impact your study.

Thoroughly planned resupply strategies and carefully calibrated shipment timing are crucial to maintaining clinical supply inventories as drug products enter late-stage development. In this Q&A, Philip Johnston, clinical supply lead, discusses best practices for efficient and timely clinical resupply and how to execute successful supply chain strategies.

When Phase 2 of a clinical study is split into multiple parts, clinical supply needs might vary from Phase 2a to Phase 2b. Important supply decisions for 2a need to be made with 2b in mind to help minimize cost and avoid time delays. Explore how sponsors can successfully navigate clinical supply decisions for a multipart Phase 2 study.